https://nemati.ai/en/blog/aprea-expands-development-of-wee1-inhibitor-after-seeing-early-clinical-activity-signs-vs-cancer 2026-08-27T20:30:19.810Z https://nemati.ai/en/blog/the-next-wave-of-adc-innovation-the-science-behind-dual-payload-bioconjugates 2026-08-27T20:30:22.000Z https://nemati.ai/en/blog/ancient-peptides-resurrected-from-lactoferrins-evolutionary-past-could-point-to-new-antibiotics 2026-08-26T23:30:26.780Z https://nemati.ai/en/blog/myotis-bat-genomes-reveal-how-they-fight-viruses-cancer-and-cellular-damage 2026-08-26T20:30:16.892Z https://nemati.ai/en/blog/centrix-and-university-of-sussex-collaborate-to-drive-data-driven-pharma-development 2026-08-26T17:30:25.633Z https://nemati.ai/en/blog/parp-inhibitor-combination-therapy-boosts-antitumor-activity-in-nsclc-models 2026-08-25T02:30:20.678Z https://nemati.ai/en/blog/small-molecules-big-expectations-how-cdmos-are-helping-sponsors-navigate-complexity-speed-scale-up-and-sustainability 2026-08-24T23:30:22.380Z https://nemati.ai/en/blog/meteorite-dust-holds-records-of-magnetism-that-may-have-helped-form-the-sun 2026-08-24T23:30:26.251Z https://nemati.ai/en/blog/ai-identifies-pre-existing-antimicrobial-antibody-profile-that-may-predict-immune-response-to-vaccination 2026-08-20T23:30:24.947Z https://nemati.ai/en/blog/is-targeted-protein-degradation-the-break-neurology-needs 2026-08-20T23:30:25.195Z https://nemati.ai/en/blog/human-multi-organ-chip-offers-new-insight-into-cancer-metastasis 2026-08-19T23:30:15.230Z https://nemati.ai/en/blog/rare-immune-cell-type-in-supercentenarians-may-help-maintain-healthy-aging 2026-08-19T23:30:18.718Z https://nemati.ai/en/blog/car-t-manufacturing-innovation-expands-patient-access 2026-08-19T20:30:23.905Z https://nemati.ai/en/blog/cutting-costs-in-serum-free-fgf2-processing-with-recycled-media 2026-08-19T20:30:24.166Z https://nemati.ai/en/blog/exercise-boosting-molecule-may-help-improve-muscle-health-in-type-2-diabetes 2026-08-18T17:30:14.684Z https://nemati.ai/en/blog/albumin-fused-antibodies-may-reduce-fetal-exposure-to-therapeutics 2026-08-18T02:30:23.807Z https://nemati.ai/en/blog/malaria-mosquito-bites-turned-into-immune-boosters-in-new-chemovaccination-strategy 2026-08-17T23:30:21.143Z https://nemati.ai/en/blog/rewriting-disease-oligonucleotides-take-aim-at-the-untreatable 2026-08-17T20:30:13.964Z https://nemati.ai/en/blog/human-cell-atlas-at-10-a-decade-of-discovery-and-the-road-to-hca-20 2026-08-17T20:30:17.056Z https://nemati.ai/en/blog/pharma-races-to-scale-ai-as-billions-flow-into-drug-discovery 2026-08-17T20:30:18.614Z https://nemati.ai/en/blog/your-ai-is-only-as-good-as-your-inputs 2026-08-17T17:30:26.655Z https://nemati.ai/en/blog/malaria-causing-plasmodium-in-uganda-show-rapid-spread-of-drug-resistance-mutations 2026-08-17T14:30:22.509Z https://nemati.ai/en/blog/modeling-legal-emancipation-for-healthcare-access-control-with-fhir-consent 2026-08-17T02:30:23.197Z https://nemati.ai/en/blog/cdmos-expand-and-build-for-future-growth 2026-08-15T20:30:16.322Z https://nemati.ai/en/blog/evolutionarily-diverse-organisms-switch-genes-on-simply-and-switch-them-off-dynamically 2026-08-03T20:30:22.984Z https://nemati.ai/en/blog/receptorai-and-sethera-plan-to-create-closed-loop-discovery-and-optimization-workflow-for-difficult-therapeutic-targets 2026-08-03T14:30:13.522Z https://nemati.ai/en/blog/stockwatch-capricor-plunges-as-fda-panel-staff-question-effectiveness-of-lead-candidate-deramiocel 2026-08-03T02:30:16.495Z https://nemati.ai/en/blog/around-the-world-in-383-days 2026-08-02T20:30:21.278Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-lilly-obesity-drug-data-a-push-for-fda-to-ban-dtc-ads-and-more 2026-07-23T17:30:21.621Z https://nemati.ai/en/blog/transcripta-bio-raises-24m-for-ai-driven-neurological-disease-therapies 2026-07-22T20:30:20.799Z https://nemati.ai/en/blog/ucsd-igi-partnership-expands-crispr-innovation-across-health-agriculture-and-the-environment 2026-07-22T02:30:17.166Z https://nemati.ai/en/blog/early-genomic-indicators-of-praziquantel-resistance-in-schistosoma-mansoni 2026-07-21T02:30:21.696Z https://nemati.ai/en/blog/flu-virus-interaction-with-host-cell-machinery-mapped-inside-infected-cells 2026-07-21T08:30:16.642Z https://nemati.ai/en/blog/protein-protects-against-tau-tangles-synaptic-loss-in-mouse-model-of-tauopathy 2026-07-20T23:30:16.896Z https://nemati.ai/en/blog/patient-derived-tumor-organoids-show-promise-for-personalizing-cancer-treatment 2026-07-20T23:30:17.513Z https://nemati.ai/en/blog/first-in-human-stem-cell-therapy-trial-for-huntingtons-disease-begins-at-uci-health 2026-06-24T23:30:28.503Z https://nemati.ai/en/blog/gene-editing-pioneer-sangamo-files-for-chapter-11-bankruptcy-agrees-to-sell-assets 2026-06-24T05:30:16.624Z https://nemati.ai/en/blog/nvidia-unveils-science-reasoning-ai-suite-with-bionemo-agent-toolkit 2026-06-23T20:30:17.663Z https://nemati.ai/en/blog/nextgen-platform-combines-vectorbuilder-and-maxcyte-technologies-to-boost-clinical-grade-cell-engineering 2026-06-23T20:30:20.576Z https://nemati.ai/en/blog/longrange-gene-networks-uncover-641-new-schizophreniaassociated-genes 2026-06-23T05:30:29.392Z https://nemati.ai/en/blog/astronomers-map-a-magnetic-skeleton-funneling-gas-into-a-stellar-nursery 2026-06-22T17:30:24.843Z https://nemati.ai/en/blog/stockwatch-positive-phase-iii-data-sells-investors-on-intellia 2026-06-22T02:30:23.169Z https://nemati.ai/en/blog/merck-protillion-launch-ai-drug-discovery-collaboration-with-up-to-510m-in-milestone-payments 2026-06-17T05:30:26.346Z https://nemati.ai/en/blog/pancreatic-cancer-cell-death-triggered-by-caspase8-blockade-in-preclinical-models 2026-06-17T05:30:32.294Z https://nemati.ai/en/blog/six-takeaways-from-the-danaher-bioprocessing-summit 2026-06-17T02:30:31.769Z https://nemati.ai/en/blog/single-cell-rna-sequencing-reveals-gene-activity-changes-in-crohns-disease 2026-06-16T23:30:21.864Z https://nemati.ai/en/blog/therapy-resistant-residual-cancer-cell-dependencies-mapped 2026-06-16T05:30:24.437Z https://nemati.ai/en/blog/silica-nanoparticles-induce-ferroptosis-reprogram-immunity-in-prostate-cancer-models 2026-06-16T05:30:30.082Z https://nemati.ai/en/blog/mrna-flu-vaccine-shows-stronger-longer-lasting-immune-response 2026-06-15T23:30:28.106Z https://nemati.ai/en/blog/zobio-introduces-dna-encoded-library-service-for-exploratory-drug-discovery-programs 2026-06-15T23:30:33.918Z https://nemati.ai/en/blog/stockwatch-parabilis-medicines-makes-wall-street-history-with-7705m-ipo 2026-06-15T02:30:26.292Z https://nemati.ai/en/blog/collagen-resides-inside-cells-in-liquid-condensate-like-form 2026-06-14T14:30:25.156Z https://nemati.ai/en/blog/hantavirus-one-shot-mrna-vaccine-fully-protects-in-syrian-hamster-model 2026-06-12T23:30:32.820Z https://nemati.ai/en/blog/sonothera-raises-125m-to-develop-ultrasound-mediated-genetic-medicines 2026-06-12T23:30:34.930Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-a-discontinued-cancer-drug-a-novo-security-breach-and-more 2026-06-12T17:30:26.496Z https://nemati.ai/en/blog/laserdriven-phase-contrast-enhances-cryoem-resolution-of-small-proteins 2026-06-12T08:30:29.274Z https://nemati.ai/en/blog/origins-of-first-eukaryotes-linked-to-contributions-from-multiple-bacteria-and-giant-viruses 2026-06-10T23:30:21.711Z https://nemati.ai/en/blog/in-silico-devices-may-improve-drug-manufacturability 2026-06-10T20:30:28.817Z https://nemati.ai/en/blog/gorilla-adenovirus-brings-natural-edge-to-cancer-therapy 2026-06-10T20:30:29.139Z https://nemati.ai/en/blog/updated-amplification-tool-rapidly-detects-mycoplasma 2026-06-10T20:30:29.434Z https://nemati.ai/en/blog/innovative-tech-testing-in-response-to-gmp-revisions 2026-06-10T20:30:29.705Z https://nemati.ai/en/blog/mrna-tails-play-key-role-in-folding-regulatory-proteins 2026-06-10T17:30:23.487Z https://nemati.ai/en/blog/10x-genomics-acquires-proteintech-genomics-expanding-proteomics-capablities 2026-06-10T17:30:24.317Z https://nemati.ai/en/blog/t-cell-synapse-formation-is-restrained-by-ptpn22-pstpip1-signaling 2026-06-10T05:30:28.079Z https://nemati.ai/en/blog/first-in-human-trial-reports-promising-dual-lassa-rabies-vaccine-data 2026-06-09T23:30:24.182Z https://nemati.ai/en/blog/incyte-to-acquire-vega-therapeutics-for-up-to-2b-growing-hematology-pipeline-with-phase-iii-vwd-candidate 2026-06-09T23:30:25.050Z https://nemati.ai/en/blog/fifteenth-in-vivo-lentiviral-vector-based-therapeutic-technology-added-to-vivebiotechs-cgt-platform 2026-06-09T23:30:28.530Z https://nemati.ai/en/blog/ai-reimagines-caffeine-as-a-molecular-offswitch-for-engineered-cells 2026-06-09T05:30:22.419Z https://nemati.ai/en/blog/chikungunya-vaccine-development-in-africa-accelerated-by-act-chik 2026-06-08T23:30:23.713Z https://nemati.ai/en/blog/citesentinel-launched-to-detect-and-prevent-ai-hallucinations-in-legal-citations 2026-06-08T20:30:32.299Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-lilly-and-pfizer-obesity-drug-data-roche-and-jj-deals-and-more 2026-06-08T17:30:27.571Z https://nemati.ai/en/blog/stockwatch-abivax-survives-a-roller-coaster-week 2026-06-07T23:30:19.516Z https://nemati.ai/en/blog/how-germinal-centers-generate-antibodies-through-noisy-rounds-of-mutation-and-selection 2026-06-05T23:30:26.642Z https://nemati.ai/en/blog/twin-prime-editing-enables-rapid-trait-stacking-in-crops 2026-06-05T23:30:27.459Z https://nemati.ai/en/blog/bio-techne-refeyn-partner-on-workflow-for-bispecific-antibody-biosimilar-characterization 2026-06-05T23:30:31.979Z https://nemati.ai/en/blog/a-billion-dollar-deal-trial-trouble-biohub-updates-and-vaccine-research-news 2026-06-05T20:30:23.134Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-roche-accusing-us-of-blackmail-a-ruling-on-skinny-labels-and-more 2026-06-05T17:30:24.686Z https://nemati.ai/en/blog/ddseq-uses-base-editing-to-map-dna-protein-interactions-in-single-cells 2026-06-05T05:30:19.105Z https://nemati.ai/en/blog/novel-intracellular-pathway-identified-that-protects-against-viral-and-bacterial-infection 2026-06-05T05:30:19.684Z https://nemati.ai/en/blog/open-letter-in-support-of-mandatory-nucleic-acid-synthesis-screening-and-recordkeeping 2026-06-05T02:30:21.569Z https://nemati.ai/en/blog/experimental-adjuvant-could-strengthen-mucosal-immunity-with-injectable-polio-vaccines 2026-06-04T23:30:23.361Z https://nemati.ai/en/blog/stipple-bio-and-lonza-agree-to-focus-on-advancing-oncology-adc-therapies 2026-06-04T23:30:25.410Z https://nemati.ai/en/blog/lilly-ascidian-launch-up-to-19b-rna-exon-editor-collaboration-targeting-inherited-kidney-diseases 2026-06-03T17:30:24.984Z https://nemati.ai/en/blog/cross-reactive-t-cells-could-point-to-broad-vaccines-or-treatments-for-measles-nipah-virus 2026-06-03T02:30:29.607Z https://nemati.ai/en/blog/fulcrum-halts-development-of-scd-candidate-pociredir-sets-strategic-review 2026-06-03T02:30:30.586Z https://nemati.ai/en/blog/disease-detection-gets-boost-from-kecks-new-brain-reference-map 2026-06-02T23:30:24.278Z https://nemati.ai/en/blog/low-cost-portable-biotech-tools-improve-access-to-bioresearch-and-diagnostics 2026-06-02T17:30:24.411Z https://nemati.ai/en/blog/circio-and-genassist-collaborate-on-gene-therapy-for-muscle-disease-and-in-vivo-cell-therapy 2026-06-02T17:30:26.601Z https://nemati.ai/en/blog/attacking-gout-crystalys-sees-room-for-its-dotinurad-and-other-allopurinol-alternatives 2026-06-01T20:30:22.147Z https://nemati.ai/en/blog/neuropixels-opto-integrates-electrophysiology-and-optogenetics-to-probe-neuronal-function 2026-06-01T20:30:29.270Z https://nemati.ai/en/blog/pharmas-trial-problem-outdated-systems-broken-data-and-the-coming-ai-reset 2026-06-01T23:30:21.801Z https://nemati.ai/en/blog/targeted-protein-degradation-broadens-its-scope 2026-06-01T23:30:23.067Z https://nemati.ai/en/blog/organ-chips-move-towards-mainstream-drug-development-with-hurdles-ahead 2026-06-01T23:30:24.258Z https://nemati.ai/en/blog/state-of-the-diagnostic-industry-recombinants-on-the-rise 2026-06-01T23:30:27.303Z https://nemati.ai/en/blog/one-antibody-fewer-scientific-surprises 2026-06-01T14:30:29.294Z https://nemati.ai/en/blog/illuminating-the-drug-development-path-with-cell-based-reporter-assays 2026-06-01T14:30:29.642Z https://nemati.ai/en/blog/corning-advances-the-organoid-revolution 2026-06-01T14:30:29.994Z https://nemati.ai/en/blog/evaluating-cns-anti-inflammatory-therapies-with-human-brain-organoids 2026-06-01T14:30:30.363Z https://nemati.ai/en/blog/soonthe-first-organ-on-a-chip-qualified-drug-development-tool 2026-06-01T17:30:19.812Z https://nemati.ai/en/blog/spatial-atlasing-why-sensitivity-is-the-real-frontier 2026-06-01T17:30:20.291Z https://nemati.ai/en/blog/propuretm-endotoxin-free-proteins-for-reliable-cancer-research 2026-06-01T17:30:20.662Z https://nemati.ai/en/blog/measuring-direct-bystander-and-off-target-adc-killing-with-the-hibit-tck-platform 2026-06-01T17:30:21.065Z https://nemati.ai/en/blog/stockwatch-agilent-shares-jump-on-better-than-expected-quarterly-results 2026-06-01T02:30:22.956Z https://nemati.ai/en/blog/collaborative-drug-discovery-inks-deal-with-eli-lilly-to-accelerate-biotech-innovation 2026-05-21T08:30:23.594Z https://nemati.ai/en/blog/helix-ai-model-accurately-predicts-rna-splicing-unlocks-precision-medicine 2026-05-21T08:30:24.219Z https://nemati.ai/en/blog/standardizing-cell-therapy-production-with-technology-facelift 2026-05-21T14:30:18.069Z https://nemati.ai/en/blog/mutating-antibodies-for-easier-drug-conjugate-manufacturing 2026-05-21T14:30:18.417Z https://nemati.ai/en/blog/mixed-reality-fermentation-simulator-preps-workforce 2026-05-21T14:30:18.887Z https://nemati.ai/en/blog/biomanufacturing-could-reshape-organ-transplantation 2026-05-21T14:30:19.401Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-biotech-investors-mood-a-former-fda-heads-confidence-and-more 2026-05-20T17:30:23.693Z https://nemati.ai/en/blog/regeneron-parabilis-ink-up-to-23b-antibody-peptide-conjugate-collaboration 2026-05-20T05:30:16.211Z https://nemati.ai/en/blog/how-gut-bacteria-apply-reversible-epigenetic-bet-hedging-strategy-to-adapt-to-change 2026-05-19T23:30:24.724Z https://nemati.ai/en/blog/kraig-biocraft-labs-creates-immortalized-silk-gland-cell-line 2026-05-19T23:30:25.699Z https://nemati.ai/en/blog/google-deepmind-and-edison-are-building-the-ai-scientist 2026-05-19T20:30:15.446Z https://nemati.ai/en/blog/codon-optimization-isnt-equal-benchmarking-gene-design-for-antibody-expression 2026-05-19T05:30:17.527Z https://nemati.ai/en/blog/multiple-sclerosis-myelin-loss-revealed-by-transcriptomic-analysis-in-mice 2026-05-18T23:30:18.814Z https://nemati.ai/en/blog/drug-target-for-fragile-x-syndrome-identified-through-preclinical-study 2026-05-18T23:30:19.493Z https://nemati.ai/en/blog/organ-on-chip-method-designed-to-zero-in-on-connection-between-diabetes-and-dementia 2026-05-18T23:30:21.089Z https://nemati.ai/en/blog/molecular-anchors-help-tumor-therapies-stay-longer-on-cancer-cells 2026-05-15T02:30:27.008Z https://nemati.ai/en/blog/visualizing-receptor-transport-within-neurons-via-transcytosis 2026-05-14T02:30:16.751Z https://nemati.ai/en/blog/bms-hengrui-pharma-partner-on-13-programs-in-up-to-152b-collaboration 2026-05-14T05:30:17.577Z https://nemati.ai/en/blog/asgct-president-terry-flotte-touts-rare-disease-initiatives-as-his-term-ends 2026-05-14T02:30:21.035Z https://nemati.ai/en/blog/synthesizing-a-natural-sunscreen-and-antioxidant-in-e-coli 2026-05-14T02:30:21.336Z https://nemati.ai/en/blog/stat-the-biotech-news-you-need-to-read-today 2026-05-10T11:30:30.635Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-an-fda-gender-rule-change-its-program-for-one-day-inspections-and-more 2026-05-09T05:30:19.914Z https://nemati.ai/en/blog/stat-novo-nordisks-less-bad-news-on-its-wegovy-pill-boosts-earnings-and-share-price 2026-05-06T17:30:19.301Z https://nemati.ai/en/blog/stat-katherine-szarama-named-acting-director-of-fdas-vaccines-and-biologics-center 2026-05-04T02:30:30.086Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-the-fda-speeding-up-trials-a-supreme-court-hearing-on-skinny-labels-and-more 2026-04-29T17:30:20.487Z https://nemati.ai/en/blog/stat-fda-launches-effort-to-speed-up-clinical-trials-using-ai 2026-04-30T05:30:19.514Z https://nemati.ai/en/blog/stat-astellas-retries-xlmtm-gene-therapy-after-deaths 2026-04-27T17:30:12.357Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-a-lilly-deal-an-intellia-crispr-rare-disease-treatment-and-more 2026-04-27T17:30:12.575Z https://nemati.ai/en/blog/stat-trump-celebrates-closing-first-round-of-drug-pricing-deals-promises-more-ahead 2026-04-25T20:40:55.485Z https://nemati.ai/en/blog/post-hoc-live-maha-the-new-trump-cdc-pick-and-rfks-vaccine-agenda 2026-04-25T20:41:05.061Z https://nemati.ai/en/blog/stat-legislatures-in-colorado-and-virginia-resist-moves-to-constrain-drug-affordability-boards 2026-04-25T20:41:06.833Z https://nemati.ai/en/blog/stat-sanofi-research-priorities-in-flux-as-new-ceo-logs-in 2026-04-25T20:41:07.690Z https://nemati.ai/en/blog/stat-rfk-jr-backs-off-some-maha-issues 2026-04-25T20:41:14.743Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-cheap-telehealth-visits-pharma-withholding-meds-in-europe-and-more 2026-04-25T20:38:09.604Z https://nemati.ai/en/blog/stat-at-aacr-talk-of-chinese-biotech-oncologys-comms-issue-and-more 2026-04-25T20:38:15.609Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-medicares-obesity-drug-pilot-an-experimental-roche-ms-drug-and-more 2026-04-25T20:38:23.017Z https://nemati.ai/en/blog/stat-with-successful-trials-roche-takes-its-ms-drug-to-regulators-but-safety-questions-loom 2026-04-25T20:42:25.400Z https://nemati.ai/en/blog/stat-from-revolution-medicines-more-strong-data-on-kras-drug-and-a-glimpse-of-a-novel-class-beyond-it 2026-04-25T20:42:25.773Z https://nemati.ai/en/blog/stat-at-aacr-more-strong-results-for-revolution-medicines-kras-drug-plus-assurance-from-ncis-director 2026-04-25T20:42:26.135Z https://nemati.ai/en/blog/stat-key-gop-senators-push-back-on-trumps-plan-to-cut-nih-reorganize-hhs 2026-04-25T20:42:26.899Z https://nemati.ai/en/blog/stat-insurers-refuse-to-join-medicare-pilot-offering-weight-loss-drugs-to-seniors-at-steep-discount 2026-04-25T20:42:27.252Z https://nemati.ai/en/blog/stat-rfk-jr-to-face-four-gop-doctors-at-senate-hearings 2026-04-25T20:42:34.142Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-an-fda-delay-forcing-a-biotech-to-close-a-neurocrine-deal-and-more 2026-04-06T17:30:05.845Z https://nemati.ai/en/blog/stat-small-drugmakers-facing-threat-of-tariffs-negotiate-pricing-deals-with-white-house 2026-04-26T02:30:11.676Z https://nemati.ai/en/blog/stat-trump-announces-100-tariffs-on-brand-name-drugs-with-plenty-of-carveouts 2026-04-26T02:30:11.881Z https://nemati.ai/en/blog/stat-makary-marks-one-year-at-fda-with-focus-on-achievements-in-speech-to-staff 2026-04-02T05:30:13.196Z https://nemati.ai/en/blog/stat-government-watchdog-urges-fda-to-finalize-guidance-for-advisory-committee-conflicts-of-interest 2026-04-04T02:30:08.573Z https://nemati.ai/en/blog/post-hoc-live-will-maha-vaccine-policies-be-a-political-problem-for-republicans 2026-03-30T20:30:07.087Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-trump-pushing-drug-pricing-policy-chinese-biotech-licensing-and-more 2026-03-30T17:30:04.880Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-an-fda-ok-for-a-rare-disease-drug-a-grilling-of-the-pto-chief-and-more 2026-03-26T17:30:05.528Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-a-trump-drug-pricing-flaw-a-gilead-deal-and-more 2026-03-24T17:30:04.570Z https://nemati.ai/en/blog/stat-the-potential-loophole-in-trumps-plan-to-get-other-countries-to-pay-more-for-drugs 2026-03-24T20:30:06.956Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-iran-wars-impact-on-pharma-supply-chain-a-pfizer-lyme-vaccine-and-more 2026-03-23T23:30:08.350Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-trumprx-expectations-a-high-dose-version-of-wegovy-and-more 2026-03-22T02:30:06.094Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-a-lilly-weight-loss-trial-trumprx-shortcomings-and-more 2026-03-22T11:30:05.913Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-trumprx-prices-a-jj-psoriasis-pill-and-much-more 2026-03-22T20:30:05.965Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-trumps-drug-pricing-moves-a-gsk-asthma-drug-and-more 2026-03-17T17:30:08.601Z https://nemati.ai/en/blog/stat-trump-is-getting-more-credit-than-biden-for-efforts-to-lower-drug-prices 2026-03-14T08:30:07.552Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-telehealth-prescribers-a-lilly-push-against-compounding-and-more 2026-03-12T17:30:03.742Z https://nemati.ai/en/blog/stat-novo-nordisk-is-warned-by-the-fda-for-failing-to-report-side-effects 2026-03-11T05:30:04.222Z https://nemati.ai/en/blog/watch-who-won-the-hims-vs-novo-feud 2026-03-15T08:30:04.495Z https://nemati.ai/en/blog/stat-pharmalot-were-reading-about-a-lack-of-fda-adcomms-fda-loosening-biosimilar-rules-and-more 2026-03-09T17:30:06.400Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-an-fda-uniqure-tussle-a-pfizer-obesity-drug-approval-in-china-and-more 2026-03-06T18:30:06.885Z https://nemati.ai/en/blog/post-hoc-live-what-will-the-us-government-do-about-china-biotech 2026-03-06T15:30:02.606Z https://nemati.ai/en/blog/stat-eli-lilly-launches-program-for-employers-to-subsidize-cost-of-obesity-drug-outside-insurance 2026-03-06T09:30:07.958Z https://nemati.ai/en/blog/stat-gilead-and-south-africa-are-negotiating-a-license-for-local-production-of-new-hiv-drug 2026-03-06T21:30:05.760Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-modernas-225-billion-settlement-fda-warning-letters-and-more 2026-03-04T18:30:07.260Z https://nemati.ai/en/blog/stat-prime-medicine-to-seek-approval-for-gene-editing-treatment-after-two-patient-trial 2026-03-07T15:30:04.040Z https://nemati.ai/en/blog/stat-trumps-drive-to-get-europe-to-pay-more-for-drugs-creates-uncertainty-for-countries-patients 2026-03-08T08:30:05.046Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-fda-and-a-smear-campaign-cigna-buying-a-large-pharmacy-and-more 2026-02-27T18:30:05.891Z https://nemati.ai/en/blog/mutant-p53-selective-reactivation-demonstrated-in-advanced-solid-tumors 2026-03-03T09:30:09.591Z https://nemati.ai/en/blog/city-therapeutics-pursues-next-generation-of-rnai 2026-03-03T03:30:05.388Z https://nemati.ai/en/blog/novo-nordisk-vivtex-ink-up-to-21b-deal-to-develop-oral-biologics-for-metabolic-conditions 2026-03-15T20:30:02.373Z https://nemati.ai/en/blog/de-risking-rna-therapeutics-with-high-resolution-sequencing 2026-03-03T03:30:05.829Z https://nemati.ai/en/blog/stat-fda-commissioner-marty-makary-defends-rare-disease-drug-rejections-vinay-prasad 2026-02-28T06:30:06.933Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-a-puzzling-fda-rejection-a-lilly-weight-loss-pill-and-more 2026-02-27T06:30:05.562Z https://nemati.ai/en/blog/stat-rare-disease-advocates-fume-over-fdas-mixed-signals 2026-02-27T06:30:06.291Z https://nemati.ai/en/blog/astellas-vir-biotechnology-launch-up-to-17b-prostate-cancer-collaboration 2026-03-03T09:30:09.797Z https://nemati.ai/en/blog/admet-predictions-get-ai-boost-federated-data-network-unites-pharma 2026-03-01T06:30:06.350Z https://nemati.ai/en/blog/bridging-the-translation-gap-for-regenerative-tissues 2026-03-01T15:30:08.500Z https://nemati.ai/en/blog/autonomy-and-accountability-in-bioprocessing 2026-02-28T09:30:06.430Z https://nemati.ai/en/blog/fermenter-extractor-separator-mixes-uniformly-and-is-gentle-on-cells 2026-02-25T23:03:59.208Z https://nemati.ai/en/blog/samsung-joins-cepi-vaccine-network-to-prepare-for-next-pandemic 2026-03-15T20:30:02.502Z https://nemati.ai/en/blog/stat-novo-doubles-down-on-oral-peptides 2026-03-02T03:30:09.319Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-trumps-drug-price-claims-a-novo-deal-for-obesity-drugs-and-more 2026-02-25T23:03:56.678Z https://nemati.ai/en/blog/novo-nordisk-teams-with-langer-founded-biotech-for-oral-obesity-drugs 2026-02-25T23:08:32.537Z https://nemati.ai/en/blog/precise-locations-of-oligodendrocytes-myelin-density-mapped-across-mouse-lifespan 2026-02-25T23:04:03.451Z https://nemati.ai/en/blog/processing-and-interpreting-untargeted-metabolomics-data-for-biomarker-discovery-and-drug-development 2026-02-25T23:04:03.678Z https://nemati.ai/en/blog/polymer-nanoparticle-startup-breezebio-raises-60m-for-mrna-diabetes-therapy 2026-02-25T23:08:34.057Z https://nemati.ai/en/blog/whos-leading-lgbtq-inclusion-in-biopharma-nominate-them-for-endpoints-annual-report 2026-02-25T23:08:34.315Z https://nemati.ai/en/blog/breezebio-banks-60m-to-make-more-precise-genetic-medicines 2026-02-25T23:08:34.394Z https://nemati.ai/en/blog/gsk-to-buy-pulmonary-hypertension-biotech-35pharma-for-950m 2026-02-25T23:08:36.171Z https://nemati.ai/en/blog/new-protein-like-polymers-target-degrade-undruggable-proteins-driving-cancer 2026-02-25T23:04:31.844Z https://nemati.ai/en/blog/novo-nordisk-to-slash-wegovy-list-price-in-half-in-2027 2026-02-25T23:08:44.215Z https://nemati.ai/en/blog/industry-groups-lay-legal-groundwork-against-pricing-demos 2026-02-25T23:08:44.302Z https://nemati.ai/en/blog/strategies-for-addressing-resistance-and-off-target-toxicity-in-antibody-drug-conjugates 2026-02-25T23:04:34.474Z https://nemati.ai/en/blog/stat-will-novo-nordisks-slashing-of-obesity-drug-prices-save-patients-money-it-depends 2026-02-25T23:04:35.275Z https://nemati.ai/en/blog/ucla-spinout-raises-11m-to-test-microbiome-based-weight-loss-therapy 2026-02-25T23:08:45.254Z https://nemati.ai/en/blog/beam-designs-new-approach-for-direct-correction-of-mutations-causing-pku 2026-02-25T23:04:38.064Z https://nemati.ai/en/blog/stat-drugmakers-lay-out-their-legal-arguments-against-trumps-drug-pricing-experiments 2026-02-25T23:04:38.171Z https://nemati.ai/en/blog/can-the-access-pilot-crack-a-longstanding-barrier-for-startups 2026-02-25T23:08:48.007Z https://nemati.ai/en/blog/biomarin-fails-to-find-buyer-pulls-roctavian-gene-therapy-off-market 2026-02-25T23:08:49.421Z https://nemati.ai/en/blog/novo-to-cut-glp-1-drug-prices-palvella-soars-on-study-data 2026-02-25T23:08:49.722Z https://nemati.ai/en/blog/patient-dies-in-macrogenics-cancer-study-fda-puts-trial-on-hold 2026-02-25T23:08:50.310Z https://nemati.ai/en/blog/beam-therapeutics-new-pku-program-protaras-bladder-cancer-data 2026-02-25T23:08:50.385Z https://nemati.ai/en/blog/abcuro-drug-fails-muscle-weakness-trial-development-to-continue 2026-02-25T23:08:50.882Z https://nemati.ai/en/blog/tamarind-bio-secures-136m-series-a-to-make-ai-more-accessible-for-biology 2026-02-25T23:04:43.536Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-an-fda-plan-for-ultra-rare-drugs-novo-cutting-glp-1-drug-prices-and-more 2026-02-25T06:30:03.302Z https://nemati.ai/en/blog/immedica-wins-accelerated-approval-for-once-rejected-rare-disease-drug 2026-02-25T23:08:52.671Z https://nemati.ai/en/blog/novo-searching-for-a-spark-spotlights-new-data-for-three-pronged-obesity-drug 2026-02-25T23:08:54.368Z https://nemati.ai/en/blog/new-biotech-slate-medicines-raises-130m-for-migraine-drug-from-china 2026-02-25T23:08:55.250Z https://nemati.ai/en/blog/ai-biotech-turbine-raises-25m-series-b-to-sell-virtual-lab-to-pharma 2026-02-25T23:08:55.832Z https://nemati.ai/en/blog/novo-nordisks-triple-g-is-competitive-with-lilly-in-obesity-but-likely-to-be-second-to-market 2026-02-25T23:08:56.270Z https://nemati.ai/en/blog/pfizer-buys-china-rights-to-sciwinds-approved-glp-1-drug-in-metabolic-push 2026-02-25T23:08:58.408Z https://nemati.ai/en/blog/ai-maps-subtle-human-pancreatic-tissue-changes-linked-to-type-2-diabetes 2026-02-25T23:05:18.198Z https://nemati.ai/en/blog/drug-controlled-car-t-cells-may-enable-safer-immunotherapy 2026-02-25T23:05:18.451Z https://nemati.ai/en/blog/agentic-ai-and-the-rise-of-in-silico-team-science-in-biomedical-research 2026-02-25T23:09:03.182Z https://nemati.ai/en/blog/astellas-pays-240m-cash-for-virs-prostate-cancer-drug 2026-02-25T23:09:04.390Z https://nemati.ai/en/blog/quralis-als-drug-sees-early-positive-signal-but-questions-remain 2026-02-25T23:09:05.794Z https://nemati.ai/en/blog/swiss-rockets-buys-mgi-subsidiary-complete-genomics-after-biosecure-act 2026-02-25T23:09:06.431Z https://nemati.ai/en/blog/fortress-to-sell-priority-review-voucher-for-205m 2026-02-25T23:09:07.144Z https://nemati.ai/en/blog/accelerating-gmp-quality-control-with-mass-photometry-from-development-to-release 2026-02-25T23:05:24.799Z https://nemati.ai/en/blog/what-the-fdas-priority-voucher-decision-means-for-psychedelic-drug-development 2026-02-25T23:05:27.102Z https://nemati.ai/en/blog/flagships-generate-targets-2b-valuation-with-nasdaq-ipo 2026-02-25T23:09:09.745Z https://nemati.ai/en/blog/frontier-harbour-do-licensing-deals-with-gsk-solstice 2026-02-25T23:09:12.104Z https://nemati.ai/en/blog/a-federal-experiment-opens-up-a-new-market-for-digital-health-if-it-works 2026-02-25T23:09:12.187Z https://nemati.ai/en/blog/roche-to-stop-work-on-bone-health-treatment-for-duchenne 2026-02-25T23:09:12.570Z https://nemati.ai/en/blog/stat-novos-next-gen-obesity-drug-stumbles-in-lilly-comparison-study 2026-02-25T23:07:56.366Z https://nemati.ai/en/blog/merck-reorganizes-blackstone-to-fund-trials-for-jj-drug 2026-02-25T23:09:13.201Z https://nemati.ai/en/blog/first-test-of-gene-therapy-for-rare-form-of-autism-is-underway 2026-02-25T23:09:13.736Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-pharma-lobbying-a-disappointing-novo-clinical-trial-and-much-more 2026-02-24T06:30:05.514Z https://nemati.ai/en/blog/before-agbt-kicks-off-ultima-unveils-the-ug-200 2026-02-25T23:05:32.361Z https://nemati.ai/en/blog/gossamer-bios-potential-winrevair-competitor-fails-pivotal-trial 2026-02-25T23:09:14.609Z https://nemati.ai/en/blog/gilead-to-acquire-cell-therapy-partner-arcellx-for-78b 2026-02-25T23:09:16.602Z https://nemati.ai/en/blog/stat-novo-nordisks-next-gen-obesity-drug-stumbles-in-comparison-study 2026-02-25T23:05:38.779Z https://nemati.ai/en/blog/novo-nordisks-cagrisema-beaten-by-lillys-zepbound-in-head-to-head-obesity-trial 2026-02-25T23:09:17.618Z https://nemati.ai/en/blog/stat-pharma-lobbyists-focus-on-a-surprising-new-target-the-fda 2026-02-25T23:05:40.112Z https://nemati.ai/en/blog/stat-lobbying-firms-with-close-ties-to-trump-draw-pharma-industry-clients 2026-02-25T23:05:39.976Z https://nemati.ai/en/blog/transposable-elements-in-the-dark-genome 2026-02-25T23:05:51.656Z https://nemati.ai/en/blog/moonlake-has-confidence-ahead-of-fda-submission-discloses-mid-stage-arthritis-win 2026-02-25T23:09:24.749Z https://nemati.ai/en/blog/stockwatch-fda-reversal-boosts-moderna-but-not-other-vaccine-companies 2026-02-22T06:30:02.372Z https://nemati.ai/en/blog/sensei-steps-back-from-brink-by-finding-faeth-and-its-phase-2-stage-cancer-drug 2026-02-21T19:36:01.836Z https://nemati.ai/en/blog/compass-guides-psychedelic-therapy-to-2nd-pivotal-depression-win-triggering-approval-push 2026-02-21T19:36:01.782Z https://nemati.ai/en/blog/chutes-amp-laddersroche-taps-aussie-oncologist-to-lead-early-research 2026-02-21T19:36:01.726Z https://nemati.ai/en/blog/ionis-scraps-early-candidate-for-alzheimers-in-people-with-down-syndrome 2026-02-21T19:36:01.669Z https://nemati.ai/en/blog/daiichi-picks-former-novartis-cmo-john-tsai-to-head-up-rampd 2026-02-21T19:36:01.610Z https://nemati.ai/en/blog/jampj-halts-enrollment-in-phase-2-trial-of-ac-immune-partnered-alzheimers-therapy 2026-02-21T19:36:01.554Z https://nemati.ai/en/blog/fda-accepts-filing-for-moderna-flu-vaccine-after-swift-rethink 2026-02-21T19:36:01.492Z https://nemati.ai/en/blog/cyrano-noses-toward-pivotal-trial-after-midphase-smell-loss-win 2026-02-21T19:36:01.432Z https://nemati.ai/en/blog/supreme-court-steps-in-trumps-emergency-tariffs-struck-down 2026-02-21T19:36:01.375Z https://nemati.ai/en/blog/sanofi-points-to-key-opportunity-for-teva-partnered-ibd-in-long-term-data 2026-02-21T19:36:01.321Z https://nemati.ai/en/blog/nih-director-jay-bhattacharya-to-take-over-as-temporary-cdc-chief-media-reports 2026-02-21T19:35:59.869Z https://nemati.ai/en/blog/candel-glows-brighter-with-100m-rtw-royalty-deal-to-fund-prostate-cancer-drugs-launch 2026-02-21T19:35:59.817Z https://nemati.ai/en/blog/korsana-crosses-into-crowded-alzheimers-field-with-175m-and-anti-amyloid-antibody 2026-02-21T19:35:59.772Z https://nemati.ai/en/blog/biohaven-charts-comeback-path-after-fda-blow-placing-bets-on-obesity 2026-02-21T19:35:59.727Z https://nemati.ai/en/blog/immunology-cro-roukenbio-pens-pact-with-avs-bio-for-more-predictable-antibody-development 2026-02-21T19:35:59.686Z https://nemati.ai/en/blog/mainz-biomed-looks-to-shed-coloalert-shifts-focus-in-us 2026-02-21T19:35:59.637Z https://nemati.ai/en/blog/blood-from-pediatricians-yields-potential-new-medicines-for-respiratory-viruses 2026-02-21T19:34:25.898Z https://nemati.ai/en/blog/internal-disorder-in-lipid-nanoparticles-may-improve-cargo-delivery-in-cells 2026-02-25T23:05:59.647Z https://nemati.ai/en/blog/potential-eylea-competitor-disappoints-fda-to-review-modernas-flu-vaccine-another-rare-disease-rejection-and-more 2026-02-25T23:09:31.222Z https://nemati.ai/en/blog/vanda-gets-fda-approval-for-franchise-extending-antipsychotic 2026-02-25T23:09:33.549Z https://nemati.ai/en/blog/how-to-avoid-a-fall-by-balancing-cost-and-performance-in-drug-discovery 2026-02-21T19:30:28.149Z https://nemati.ai/en/blog/grails-cancer-test-faces-new-uncertainty-after-uk-study 2026-02-21T19:34:27.352Z https://nemati.ai/en/blog/ionis-scraps-alzheimers-drug-for-people-with-down-syndrome 2026-02-21T19:34:27.681Z https://nemati.ai/en/blog/grails-multi-cancer-early-detection-test-misses-study-goal 2026-02-21T19:34:27.931Z https://nemati.ai/en/blog/hormone-regulated-immune-cells-implicated-in-longer-lasting-pain-in-women 2026-02-21T19:30:31.360Z https://nemati.ai/en/blog/supreme-court-tariff-ruling-lets-stand-trumps-authority-to-target-pharma 2026-02-21T19:34:28.425Z https://nemati.ai/en/blog/candel-prices-offering-signs-royalty-deal-calquence-label-expands 2026-02-21T19:34:32.022Z https://nemati.ai/en/blog/daiichi-taps-john-tsai-to-lead-rd-as-ken-takeshita-departs 2026-02-21T19:34:32.291Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-an-fda-officials-speech-a-grail-cancer-blood-test-and-much-more 2026-02-21T19:30:00.501Z https://nemati.ai/en/blog/novartis-to-divest-india-unit-to-private-equity-led-consortium-for-159m 2026-02-21T19:34:34.078Z https://nemati.ai/en/blog/grails-cancer-test-misses-primary-study-goal-in-uk-study 2026-02-21T19:34:37.657Z https://nemati.ai/en/blog/electronic-mesh-spurs-islet-cell-maturation-could-aid-diabetes-care 2026-02-21T19:30:54.532Z https://nemati.ai/en/blog/vaccine-protects-against-multiple-respiratory-viruses-bacteria-and-allergens-in-mice 2026-02-21T19:30:54.629Z https://nemati.ai/en/blog/inside-agbt-big-announcements-and-bigger-implications 2026-02-21T19:30:56.308Z https://nemati.ai/en/blog/stat-in-first-speech-to-her-fda-staff-heg-says-shell-scrutinize-rsv-shots-and-ssris-in-pregnancy 2026-02-21T19:30:56.656Z https://nemati.ai/en/blog/plasma-p-tau217-clocks-estimate-timing-of-alzheimers-symptom-onset 2026-02-21T19:30:57.073Z https://nemati.ai/en/blog/lower-glucose-by-living-high 2026-02-21T19:30:57.318Z https://nemati.ai/en/blog/abbvie-phrma-can-proceed-with-340b-case-in-hawaii 2026-02-21T19:34:41.605Z https://nemati.ai/en/blog/when-a-health-tech-startup-gets-stuck-in-regulatory-limbo 2026-02-21T19:34:41.744Z https://nemati.ai/en/blog/teva-beats-corcept-in-appeals-fight-over-generic-cushings-syndrome-drug 2026-02-21T19:34:41.832Z https://nemati.ai/en/blog/lonza-boosts-advanced-synthesis-capabilities-for-bioconjugates 2026-02-21T19:30:58.135Z https://nemati.ai/en/blog/stat-5-powerful-people-to-know-at-hhs 2026-02-21T19:30:59.088Z https://nemati.ai/en/blog/fda-formalizes-one-pivotal-trial-policy-via-nejm-perspective 2026-02-21T19:34:43.243Z https://nemati.ai/en/blog/obesity-biotech-verdiva-plans-big-year-of-data-explores-deals 2026-02-21T19:34:43.284Z https://nemati.ai/en/blog/fda-leaders-say-one-pivotal-trial-not-two-should-be-default-for-drug-approvals 2026-02-21T19:34:43.530Z https://nemati.ai/en/blog/biogen-stops-part-of-an-ms-trial-merck-reports-more-enflonsia-data 2026-02-21T19:34:43.573Z https://nemati.ai/en/blog/sanofi-to-expand-in-india-stada-invests-100m-in-saudi-arabia 2026-02-21T19:34:43.648Z https://nemati.ai/en/blog/hims-to-buy-australias-eucalyptus-for-240m-upfront-in-global-push 2026-02-21T19:34:44.198Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-the-fda-pushing-otc-meds-its-new-trial-standards-and-much-more 2026-02-21T19:30:11.562Z https://nemati.ai/en/blog/altesa-raises-75m-for-oral-respiratory-med 2026-02-21T19:34:47.179Z https://nemati.ai/en/blog/jj-pauses-patient-recruitment-in-mid-stage-trial-of-ac-immunes-alzheimers-drug 2026-02-21T19:34:47.373Z https://nemati.ai/en/blog/opinion-my-biggest-glp-1-ethical-problem-patients-who-dont-want-to-stop 2026-02-21T19:33:10.451Z https://nemati.ai/en/blog/on-its-15th-anniversary-foresite-capital-looks-ahead 2026-02-21T19:31:05.087Z https://nemati.ai/en/blog/cancer-immunotherapy-improved-using-targeted-stress-protein 2026-02-21T19:31:05.179Z https://nemati.ai/en/blog/microalgae-as-cellular-factories-for-molecular-crystals 2026-02-21T19:34:48.216Z https://nemati.ai/en/blog/stat-new-fda-guidance-for-antibiotic-use-in-food-producing-animals-prompts-criticism-over-antibiotic-resistance 2026-02-21T19:31:05.549Z https://nemati.ai/en/blog/novartis-unp-launch-up-to-18b-macrocyclic-peptide-partnership 2026-02-21T19:31:05.689Z https://nemati.ai/en/blog/spt-labtech-bellbrook-labs-automate-screening-for-vps4b-atpase-inhibitors-for-cancer-drug-discovery 2026-02-21T19:31:05.748Z https://nemati.ai/en/blog/why-clinical-ai-startup-kintsugi-shut-down 2026-02-21T19:34:48.884Z https://nemati.ai/en/blog/senate-health-committee-chair-plots-future-fda-changes 2026-02-21T19:34:48.968Z https://nemati.ai/en/blog/pharma-is-done-negotiating-as-trump-pushes-to-codify-deals 2026-02-21T19:34:49.169Z https://nemati.ai/en/blog/jj-pours-1b-into-new-cell-therapy-site-in-pennsylvania 2026-02-21T19:34:49.576Z https://nemati.ai/en/blog/charles-river-highlights-increase-in-demand-as-tariff-uncertainties-fade 2026-02-21T19:34:49.712Z https://nemati.ai/en/blog/reversal-on-modernas-flu-application-follows-atypical-path-through-fda 2026-02-21T19:34:50.272Z https://nemati.ai/en/blog/lillys-zepbound-taltz-combo-data-in-psoriasis-and-weight-loss-novartis-bolsters-rhapsido-results 2026-02-21T19:34:50.516Z https://nemati.ai/en/blog/stat-investors-cheer-compass-psilocybin-data 2026-02-21T19:33:13.826Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-an-fda-reversal-on-a-moderna-vaccine-the-uk-life-sciences-sector-and-more 2026-02-21T19:30:14.691Z https://nemati.ai/en/blog/faeth-goes-public-in-merger-with-sensei-nets-200m-in-stock-sale 2026-02-21T19:34:51.269Z https://nemati.ai/en/blog/neuexcell-therapeutics-brain-cancer-therapy-tests-debated-field 2026-02-21T19:34:51.417Z https://nemati.ai/en/blog/lilly-licenses-csls-il-6-immuno-inflammatory-antibody-for-100m-upfront 2026-02-21T19:34:52.853Z https://nemati.ai/en/blog/paragons-new-biotech-korsana-tackles-alzheimers-like-roche 2026-02-21T19:34:53.070Z https://nemati.ai/en/blog/opinion-i-was-a-moderna-exec-when-the-covid-vaccine-rolled-out-that-spirit-of-possibility-is-no-more 2026-02-21T19:33:14.934Z https://nemati.ai/en/blog/stat-at-drugmakers-forum-oz-gets-a-friendly-embrace-while-makary-faces-tough-questions 2026-02-21T19:31:09.978Z https://nemati.ai/en/blog/compass-with-phase-3-hits-ready-to-take-psilocybin-to-the-fda 2026-02-21T19:34:54.978Z https://nemati.ai/en/blog/stat-psilocybin-data-could-be-good-enough-for-approval 2026-02-21T19:33:16.645Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-chinas-homegrown-glp-1-drugs-a-puzzling-fda-rejection-and-more 2026-02-21T19:30:16.253Z https://nemati.ai/en/blog/stat-oculars-experimental-eye-drug-beats-low-dose-of-regenerons-eylea-in-late-stage-trial 2026-02-21T19:31:12.313Z https://nemati.ai/en/blog/stat-compass-says-its-psilocybin-drug-helped-patients-with-severe-depression-in-two-trials 2026-02-21T19:31:12.512Z https://nemati.ai/en/blog/stat-pediatricians-confront-hhs-in-vaccine-showdown 2026-02-21T19:33:20.534Z https://nemati.ai/en/blog/stat-pharmalittle-were-reading-about-lilly-bulking-up-on-weight-loss-drugs-scrutiny-of-a-340b-contractor-and-more 2026-02-21T19:30:18.465Z https://nemati.ai/en/blog/stat-trump-administration-is-urged-to-use-a-federal-law-to-authorize-generic-versions-of-glp-1-drugs 2026-02-21T19:31:19.110Z https://nemati.ai/en/blog/stat-fdas-rejection-of-moderna-threatens-to-stifle-broader-vaccine-industry 2026-02-21T19:31:19.422Z https://nemati.ai/en/blog/stat-the-messaging-war-over-medicaid-cuts 2026-02-21T19:31:19.493Z